HD-OPM Archive
Topics › Statins

SAMSON trial design: statin, placebo and empty bottles show side effects are mostly nocebo

Louis Nervegna · Jul 21, 2025 · ♥ 3 reactions · 9 comments · original Facebook post
StatinsHow to read research
↻ This is a repost. The main version (highest ranked) is N-of-1 trial: most statin side effects arose with placebo too, pointing to nocebo · Feb 24, 2025.
AI summary & key facts

Louis explains the SAMSON N-of-1 design: patients who stopped statins received monthly bottles of statin, placebo or nothing in random order. Symptoms were minimal with no pill but similar with placebo and statin, implying about 90% of side effects are nocebo, and half of participants restarted statins.

On any given month, the participants were randomized to either a statin, a placebo, or nothing at all.

What happened is that participants reported very little side effects from taking nothing— but lots of side effects from taking either the placebo or the statin.

The only reasonable explanation for that is nocebo effect. In this study, 90% of the side effects were due to nocebo effect.

↪ Nocebo effect explained about 90% of symptoms in patients who quit statins (SAMSON trial)

The nocebo effect occurs when your mind creates physical symptoms in response to the thought that you are taking something (e.g. a pill or shot) that is somehow harming you. These physical symptoms are very real, but in the case of the nocebo effect, they are generated entirely by the mind. Not by the thing you are taking.

People who are prone to conspiratorial lines of thinking about medical topics are much more likely to experience nocebo effect. This is why you should always take testimonials from these people with a grain of salt.

facebook.com/share/r/1BPLbqjcwe

#noceboHD #statinsHD #nejmHD #samsonHD

Research cited

Patients who had discontinued statins because of side effects received four one-month bottles of a statin, four bottles of placebo, and four empty bottles, randomly sequenced, each to be used for 1 month. Symptom burden with placebo was not significantly different to the symptom burden with the statin, and half the study participants were able to successfully restart statins.

← newer: Nocebo effect explains about 90% of symptoms in patients whoolder: Why negative anecdotes about standard treatments deserve ske →